霉酚酸酯引起的伴有皮肤表现的高脂血症。
Mycophenolate mofetil-induced hyperlipidemia with cutaneous manifestations.
作者信息
Yim Rebecca M, Sahni Vikram N, Mathis Jason G
机构信息
Tulane University School of Medicine New Orleans Louisiana USA.
Department of Dermatology University of Utah Salt Lake City Utah USA.
出版信息
Clin Case Rep. 2023 Mar 14;11(3):e7056. doi: 10.1002/ccr3.7056. eCollection 2023 Mar.
Abstract
We report a case of a 49 year old woman who developed biopsy-proven xanthomas on her hands and arms after initiation of Mycophenolate mofetil therapy for systemic lupus erythematosus (SLE) and subsequently went into remission upon cessation of the medication.
摘要
我们报告一例49岁女性，她在开始使用霉酚酸酯治疗系统性红斑狼疮（SLE）后，手部和手臂出现经活检证实的黄瘤，随后在停药后病情缓解。
相似文献
1
Mycophenolate mofetil-induced hyperlipidemia with cutaneous manifestations.霉酚酸酯引起的伴有皮肤表现的高脂血症。
Clin Case Rep. 2023 Mar 14;11(3):e7056. doi: 10.1002/ccr3.7056. eCollection 2023 Mar.
2
Bullous Systemic Lupus Erythematosus Successfully Treated With Intravenous Immunoglobulin and Mycophenolate Mofetil.静脉注射免疫球蛋白和霉酚酸酯成功治疗大疱性系统性红斑狼疮
Cureus. 2023 Sep 22;15(9):e45800. doi: 10.7759/cureus.45800. eCollection 2023 Sep.
3
Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.尼日利亚的罗威尔综合征：一名年轻女性中表现为复发性多形红斑的系统性红斑狼疮
Acta Dermatovenerol Croat. 2019 Sep;27(3):200-201.
4
Pigmented villonodular synovitis of the hip in systemic lupus erythematosus: a case report.系统性红斑狼疮伴发的髋关节色素沉着绒毛结节性滑膜炎：一例报告
J Med Case Rep. 2011 Sep 7;5:443. doi: 10.1186/1752-1947-5-443.
5
Role of Anifrolumab in Refractory Cutaneous Manifestations of Lupus Erythematosus: A Case Series and Literature Review.阿尼鲁单抗在红斑狼疮难治性皮肤表现中的作用：病例系列及文献综述
Cureus. 2023 May 27;15(5):e39553. doi: 10.7759/cureus.39553. eCollection 2023 May.
6
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.霉酚酸酯治疗系统性红斑狼疮的非肾脏表现：一项观察性队列研究
J Rheumatol. 2016 Mar;43(3):552-8. doi: 10.3899/jrheum.150779. Epub 2016 Jan 15.
7
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.霉酚酸酯或静脉注射环磷酰胺作为狼疮性肾炎诱导治疗后的非肾疾病活动：一项多中心、前瞻性、随机、开放标签、平行组临床试验的结果
Arthritis Rheum. 2010 Jan;62(1):211-21. doi: 10.1002/art.25052.
8
Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy.霉酚酸酯作为一线治疗方案用于经活检证实的狼疮性肾炎患者的临床观察结果
Cureus. 2017 Dec 4;9(12):e1907. doi: 10.7759/cureus.1907.
9
Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil.霉酚酸酯成功治疗狼疮性肾炎相关噬血细胞性淋巴组织细胞增生症
Case Rep Rheumatol. 2017;2017:4159727. doi: 10.1155/2017/4159727. Epub 2017 Sep 14.
10
A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.一例系统性红斑狼疮伴发微小病变病患者经吗替麦考酚酯治疗后获得成功。
Korean J Intern Med. 2011 Dec;26(4):470-3. doi: 10.3904/kjim.2011.26.4.470. Epub 2011 Nov 28.
引用本文的文献
1
QSPRmodeler - An open source application for molecular predictive analytics.QSPR建模器 - 一款用于分子预测分析的开源应用程序。
Front Bioinform. 2024 Sep 23;4:1441024. doi: 10.3389/fbinf.2024.1441024. eCollection 2024.
本文引用的文献
1
Late Transformation of a Dermatofibrosarcoma Protuberans Neck Sarcoma to a Neoplasm With Fibrosarcomatous Elements: Lessons Learned.隆突性皮肤纤维肉瘤颈部肉瘤向具有纤维肉瘤成分的肿瘤的晚期转变：经验教训
Cureus. 2022 Oct 26;14(10):e30690. doi: 10.7759/cureus.30690. eCollection 2022 Oct.
2
Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia.核受体 PXR 在药物性高胆固醇血症中的作用。
Cells. 2022 Jan 18;11(3):313. doi: 10.3390/cells11030313.
3
Xanthomas and atheromas.黄色瘤和粥样瘤。
Atherosclerosis. 2017 Aug;263:315. doi: 10.1016/j.atherosclerosis.2017.06.003. Epub 2017 Jun 6.
4
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds.对一个化学文库进行筛选发现了新型的激活孕烷X受体（PXR）的药理化合物。
Toxicol Lett. 2015 Jan 5;232(1):193-202. doi: 10.1016/j.toxlet.2014.10.009. Epub 2014 Oct 16.
5
Xanthomas: clinical and pathophysiological relations.黄瘤病：临床与病理生理关系
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Jun;158(2):181-8. doi: 10.5507/bp.2014.016. Epub 2014 Apr 29.
6
Mechanisms of action of mycophenolate mofetil.霉酚酸酯的作用机制。
Lupus. 2005;14 Suppl 1:s2-8. doi: 10.1191/0961203305lu2109oa.
7
Treatment of hyperlipidemia in cardiac transplant recipients.心脏移植受者高脂血症的治疗
Am Heart J. 2004 Aug;148(2):200-10. doi: 10.1016/j.ahj.2004.03.050.
8
Xanthomas: a marker for hyperlipidemias.黄色瘤：高脂血症的一个标志物。
Bol Asoc Med P R. 2003 Jul-Aug;95(4):12-6.
9
Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels.药物诱导的脂质变化：一些常用药物对血清脂质水平意外影响的综述。
Drug Saf. 2001;24(6):443-56. doi: 10.2165/00002018-200124060-00003.
10
Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.霉酚酸酯在移植排斥反应中的初步风险效益评估。
Drug Saf. 1997 Aug;17(2):75-92. doi: 10.2165/00002018-199717020-00001.
Zotero 插件